Profound Medical Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March. At this time, Profound Medical's Property Plant And Equipment Net is most likely to increase significantly in the upcoming years. The Profound Medical's current Accounts Payable is estimated to increase to about 2.3 M, while Total Current Liabilities is projected to decrease to roughly 5.3 M.
Cash Flow Balance Sheet Income Statement
Yuan Drop
Covid
Interest Hikes
Profound Medical Balance Sheet Chart
At this time, Profound Medical's Property Plant And Equipment Net is most likely to increase significantly in the upcoming years. The Profound Medical's current Accounts Payable is estimated to increase to about 2.3 M, while Total Current Liabilities is projected to decrease to roughly 5.3 M.
The essential information of the day-to-day investment outlook for Profound Medical includes many different criteria found on its balance sheet. An individual investor should research Profound Medical's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Profound Medical.
Profound Medical competes with TriSalus Life, MaxCyte, Perspective Therapeutics, LENSAR, and Anteris Technologies. Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada. Profound Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 146 people.
Comparative valuation techniques use various fundamental indicators to help in determining Profound Medical's current stock value. Our valuation model uses many indicators to compare Profound Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Profound Medical competition to find correlations between indicators driving Profound Medical's intrinsic value. More Info.
Profound Medical Corp is regarded fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Profound Medical's Return On Equity is most likely to slightly grow in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Profound Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Most indicators from Profound Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Profound Medical Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Today, most investors in Profound Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Profound Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Profound Medical growth as a starting point in their analysis.
Price Earnings To Growth Ratio
0.72
At this time, Profound Medical's Price Earnings To Growth Ratio is most likely to increase slightly in the upcoming years.
Profound Medical February 5, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Profound Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Profound Medical Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Profound Medical Corp based on widely used predictive technical indicators. In general, we focus on analyzing Profound Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Profound Medical's daily price indicators and compare them against related drivers.
When running Profound Medical's price analysis, check to measure Profound Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profound Medical is operating at the current time. Most of Profound Medical's value examination focuses on studying past and present price action to predict the probability of Profound Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profound Medical's price. Additionally, you may evaluate how the addition of Profound Medical to your portfolios can decrease your overall portfolio volatility.